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Bradykinin is generated in human plasma by the action of plasma kallikrein 
upon kininogen (1, 2). Although Hageman factor is required for the formation 
of kallikrein  (3,  4),  the role of Hageman factor in  the formation of the pre- 
kallikrein activator is not clearly delineated. Kaplan and Austen (5)  have de- 
scribed a  prekallikrein activator present in human serum which has a  preal- 
bumin mobility on disc gel electrophoresis, an estimated molecular weight of 
35,000 by Sephadex G-100 filtration (Pharmacia Fine Chemicals Inc., Uppsala, 
Sweden),  and  the  capacity  to  correct selectively the  coagulation  defect  of 
Hageman  factor-deficient plasma.  Prolonged  dialysis  of  a  partially  purified 
preparation of active Hageman factor resulted in the development of prealbumin 
bands in the position previously noted for the prekallikrein activator derived 
from serum; the eluates of these bands had prekallikrein-activating activity and 
corrected Hageman factor deficiency. It was  therefore postulated that active 
Hageman factor dissociates into fragments which retain clot-promoting activity 
while manifesting a  striking  ability to  activate prekallikrein  (5).  Since plas- 
minogen was recognized in preparations of highly purified Hageman factor (6), 
and since plasmin has been implicated in the activation of prekallikrein (7), it 
seemed possible that plasmin was responsible for the development of prekalli- 
krein-activating activity from active Hageman factor. The cleavage of active 
Hageman  factor  by  streptokinase-activated,  highly  purified  plasminogen  to 
form the prekallikrein activator is described herein. 
Materials and Methods 
Bradykinin trlacetate  (Sandoz Pharmaceuticals, Basel, Switzerland, or  New  England 
Nuclear Corp., Cambridge, Mass.) was used as the standard for native bradykinin. Antisera 
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to IgG, IgA, IgM,  ~-lpoprotein, transferrin, albumin, and whole human serum were pur- 
chased from Behring Diagnostics, Inc., Woodbury, N.Y. Hexadimethrine  (polybrene) was a 
gift of Dr. Floyd McIntire of Abbott Laboratories (North Chicago, 111,). Hagemaa factor-de- 
ficient plasma was supplied by Dr.  O.  Ratnoff  (Cleveland,  Ohio). Plasma thromboplastin 
antecedent (PTA)l-deficient plasma was supplied by Dr.  Anthony Britton (Boston,  Mass). 
Purified plasminogen and streptokinase were gifts of Dr. E. C. DeRenzo of Lederle Labora- 
tories (American Cyanamid Co., Pearl River, N. Y.). 
Diethylamlnoethyl (DEAE)-Cellulose Chromatography.--Sera and plasma were  drawn for 
the isolation of active enzymes and proenzymes respectively and were processed as previously 
described (5). 35 ml of dialyzed serum or plasma was applied to a 3.5 X  30 cm column of packed 
DEAE-ceUUlose equilibrated with 0.01 ~a PO4 buffer, pH 7.8.  The column was washed with 
500 ml of the equilibrating buffer and eluted with a linear salt gradient of 2 liters of the equili- 
brating buffer and 2 liters of 0.01 ~a PO4 buffer, pH 7.8, containing 0.3 ~  NaC1. The column 
was run at 60 ml/hr and 12 ml fractions were collected. The eluate fractions were  assayed 
for protein content (OD 280 m#), conductivity, and various intermediates of the kinin-form- 
ing sequence. Peaks having bradykinin-generating capacity were concentrated by ultrafiltra- 
tion using a  UM-10 membrane (Amicon Corp., Lexington, Mass.) to 5-10 ml and were then 
further concentrated by wall vacuum using Collodion bags No.  100  (Schleicher and Schuell, 
Inc., Keene, N. H.). 
Carboxymethyl (CM)-Cdlulose Chromatography.--A 3.5  X  20 cm column of packed CM- 
cellulose was equilibrated with 0.01 ~ PO4 buffer, pH 6.0. 20-30 ml samples, dialyzed in 0.01 ~a 
PO4 buffer, pH 6.0, were applied to the column; the column was washed with 350 ml of equili- 
brating buffer, and a linear salt gradient using 1.5 liters of equilibrating buffer and 1.5 liters 
of 0.01 ~  PO4 buffer, pH 6.0, containing 0.75 ~  NaC1 was applied. The column was run at 60 
ml/hr and 12 ml fractions were collected. 
Disc Gel Electrophoresis.--Analytic  disc gel electrophoresis was performed at a  running 
pH of 9.3 using the equipment and directions supplied by Buchler Instruments, Inc.  (Fort 
Lee, N.J.). Samples of either 100/zl or 150 #1 were applied to the gels.  Mter electrophore- 
sis, the protein bands were stained with Coomassie blue stain (8)  and inspected visually. In 
order to corrdate the bands seen with their functional activity, a  series of disc gels was run 
simultaneously. Mter staining one gel with Coomassie blue, this gel and the unstained gels 
were sliced into either 1 mm or 2 mm sections using the gel column cutter described by Heide- 
man (9). The unstained gel sections were crushed and the proteins were ehted from each sec- 
tion by suspension in 0.5 ml of 0.15 ~  NaC1. Mter standing at room temperature for 2 hr and 
at 4°C overnight, the polyacrylamide was sedimented by centrifugation and the supernatunt 
was separated. 
Assay of Components of the Bradykinin-Generating Systera.--Bradykinin  was routinely de- 
termined by bioassay utilizing the isolated guinea pig ileum (10)  or  by  radioimmunoassay 
(11). Kallkrein, prekaUikrein, and prekallikrein-activating components were determined  as 
previously described (5). The shortening of the partial thromboplastin time of Hageman fac- 
tor-deficient plasma was used as an assay for Hageman factor. 0.0050 ml of Itageman factor 
source was incubated for 2 min at 37°C with 0.05 ml cephalin reagent (12) and 0.05 ml Hage- 
man factor-deficient plasma in siliconized glass tubes. 0.0050 ml of 0.05 ** CaC12 was  added 
and the clotting time determined at room temperature. The tubes were tilted each minute and 
the end point was defined as the time interval required for the dot to adhere to the glass tube. 
Utilization of the cephalin reagent with and without kaolin, 10 mg/ml, revealed whether or 
not Hageman factor was  already  active.  Plasma  thromboplastin antecedent activity was 
assayed  in  the same manner utilizing PTA-deficient plasma in place  of  Hageman factor- 
1 Abbreviation used in this paper: PTA, plasma thromboplastin antecedent. 698  A  P1LEALBUMIN  ACTIVATOR  OF  PREKALLIK1LEIN. IX. 
deficient plasma. Plasmin was measured by digestion of azocasein as described by Hummel 
et al.  (13).  Plasminogen,  the inactive precursor  of plasmin,  was determined  by incubating 
0.5 ml of plasmiuogen source with 250 units of streptokinase for 15 rain at 30°C, followed  by 
measurement of the plasmin  generated. 
RESULTS 
Sequential  Change ~n  Charge and  Size  of Prekallikrein-Activating  Activity 
Derived after Activation of ltageman Factor.--As demonstrated previously (5), 
five areas having bradykinin-generating activity were found when serum  was 
chromatographed  on DEAE-cellulose  and  the fractions  assayed  using  fresh 
plasma as substrate. Peak 1 eluted with the starting buffer, released bradykinin 
from either fresh plasma, heat-inactivated plasma,  or purified kininogen, and 
therefore contained kallikrein activity. Plasma thromboplastin antecedent as- 
sessed by correction of the coagulation defect of PTA-deficient plasma was also 
found in this fraction. The four peaks eluted after application of a linear gradient 
had bradykinin-generating activity when incubated with fresh plasma but not 
with heat-inactivated plasma or purified kininogen, and  therefore contained 
prekallikrein-activating  components.  Activated  Hagernan  factor  was  found 
overlapping peaks 2 and 3 with trailing of this activity through peaks 4 and 5. 
When either peak 2 or peak 3 was pooled, concentrated, dialyzed, and rechro- 
rnatographed on DEAE-cellulose under  identical conditions, the bradykinin- 
generating activity was found in the position of peak 5; when peak 5 was rechro- 
rnatographed, all of the applied activity was recovered in  the same position. 
Peak 5 therefore appeared to be derived from material initially eluting as peaks 
2 and 3.When purified by Sephadex G-100 filtration, CM-cellulose chromatog- 
raphy, and elution from disc gels after electrophoresis at pH  9.3,  peak 5  was 
shown to be a prealburnin with an approximate molecular weight of 35,000  (5). 
In  order  to examine the possible derivation of the prekallikrein activator 
from active Hagernan factor, a study was carried out in which a mixture of un- 
activated Hagernan factor and prekallikrein were isolated together from plasma 
free of prekallikrein-activating activity. The mixture was activated, fraction- 
ated by DEAE-cellulose chromatography and disc gel electrophoresis at pH 9.3, 
and each fraction assayed for Hageman factor activity and bradykinin-gener- 
ating  activity.  100 ml  of  plasma  was  processed for  the  preparation  of pro- 
enzymes of the human kinin-forming system (5),  dialyzed against 0.05 M PO4 
buffer, pH 7.5, and applied to a 5 X  100 crn column of DEAE-cellulose equili- 
brated with the same buffer.  The  effluent  contained  unactivated  Hagernan 
factor and prekallikrein and was devoid of prekallikrein-activating activity and 
kallikrein. The effluent was concentrated 10-fold and activated by storage in a 
glass vessel for 36 hr at 4°C; generation of active kallikrein was  indicated by 
the capacity of 50 #1 of effluent to produce 100 ng of bradykinin upon incuba- 
tion with 0.2 rnl of heat-inactivated plasma.  The effluent was  then dialyzed ALLEN  P. KAPLAN  AND  I~, FRANK  AIYSTEN  699 
against 0.01 ~  PO4 buffer, pH 7.8,  and  chromatographed on DEAE-cellulose 
with the results shown in Fig.  1.  Peak 1 contained kallikrein, PTA, and IgG 
and gave a broad band upon disc gel electrophoresis due to the heterogeneity of 
IgG. The subsequent three peaks were eluted at a concentration of NaC1 cor- 
responding to peaks 2-3,  4,  and 5  observed upon chromatography of whole 
serum (5). Fig. 2 shows the pattern obtained after disc gel electrophoresis of the 
fractions designated peaks 2-3, 4, and 5; a single unstained gel of each peak was 
sliced and each slice eluted in order to define the position of bradykinin-gener- 
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Fio. 1. Bradykinin generated when a plasma fraction obtained by batch  elution from 
DEAE-cellulose  at 0.05 ~ PO4 buffer, pH 7.5, is activated and rechromatographed  on DEAE- 
cellulose. 0.2 ml of the fractions obtained was incubated with 0.2 ml of fresh plasma for 2 rain 
at 37°C and the bradykinin generated determined by bioassay. 
ating activity and Hageman factor activity (Table I). The eluates of peak 2-3 
contained two peaks of bradykinin-generating activity located at 5-8 mm and 
11-12 ram,  and  a  possible  small  third peak  at  15-16 ram.  A  major peak  of 
Hageman factor activity was found at 5-8 mm and a small peak of Hageman 
factor activity was seen at 11-12 ram. The eluates of peak 4 revealed brady- 
kinin-generating  activity  at  15-16 mm.  A  major  peak  of  Hageman  factor 
activity  was  found  extending  from  14-18 mm;  however,  Hageman  factor 
activity was found throughout the first 13 slices. The disc gel eluates of peak 5 
revealed bradykinin-generating  activity from  20 mm  through  26 mm  and  a 
peak of Hageman factor activity from 23 mm through 26 ram,  corresponding 
in position to the prealbumin bands seen in the stained disc gel of the same peak 
5 in Fig. 2. SomeHageman factor activity was also found from 10 to 12 mm and 
17 to 22 ram. The peaks of bradykinin-generating activity and Hageman factor 700  A  PREALBLr~I~  ACTIVATOR  OF  PREKALLIKREII~.  II. 
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activity were both found in slice  25  corresponding to the densest of the pre- 
albumin bands seen, and an abrupt decline in both activities was observed at 
27 mm. 
When 50/~1 of the concentrates of peaks 2-3, 4, and 5 obtained from DEAE- 
cellulose  chromatography were each incubated with 0.2 ml of heat-inactivated 
plasma for 2 rain at 37°C, bradykinin was not generated, indicating the absence 
of active kallikrein in these fractions. When 50 #1 of each concentrate was incu- 
bated with 25 #I of prekallikrein for 5 rain at 37°C  and then incubated with 
FIo. 2. Disc gel electrophoresis of peaks 2-3, 4, and 5 obtained from DEAE-cellulose. 
0.2 ml of heat-inactivated plasma for 2 rain at 37°C, peaks 2-3, 4, and 5 gener- 
ated 75, 60, and 100 ng of bradykinin respectively, demonstrating the presence 
of prekallikrein activator in each concentrate. The  disc gel eluates of peaks 
2-3, 4, and 5 were assessed for the presence of prekallikrein activator by incu- 
bating 100/zl  of disc gel eluate with 50 #I of prekallikrein and then incubating 
the mixture with 0.2 ml of heat-inactivated plasma. The eluates of peak 2-3 
generated 20 ng of bradykinin at 5-6 mm and at 7-8 ram, and 10 ng of brady- 
kinin at  11-12 ram;  the eluates of peak 4  generated 10 ng of bradykinin at 
16 ram, and the eluates of peak 5 generated 25, 30, 40, 50, and 25 ng of brady- 
kinin from 22 mm through 26 ram. The positions of the peaks of bradykinin- 
generating activity of the disc gel eluates of peaks 2-3, 4, and 5, when assessed 
for the presence of prekallikrein activator, corresponded to the positions of the 
peaks of bradykinin-generating activity shown in Table I  when fresh plasma 702  A  PREALBUMIN  ACTIVATOR OF PREKALLIKREIN.  II. 
was used as substrate. When the disc gel eluates of peaks 2-3, 4, and 5 were also 
examined for their ability to shorten the partial thromboplastin time of PTA- 
deficient plasma, clot-promoting activity was not found. 
When peak 3 or peak 5 obtained from DEAE-cellulose chromatography of sera 
was subjected to Sephadex G-100 filtration, major peaks of bradykinin-gener- 
ating activity were found at 55 and 59 % bed volume and a minor peak at 50 % 
bed volume (5). Peaks 2-3, 4, and 5 obtained from DEAE-cellulose chromatog- 
raphy of the activated plasma fraction were therefore subjected to Sephadex 
G-100 filtration in order to ascertain their relative sizes. Peak 2-3 gave peaks 
of bradykinin-generating activity at 40, 50, and 60 % bed volume; peak 4 gave 
a single peak of bradykinin-generating activity at 52 % bed volume, and peak 
5  gave a  single peak of bradykinin-generating activity at 61%  bed volume. 
After Sephadex G-100 filtration of peak 4,  the material was concentrated and 
again analyzed by disc gel electrophoresis. When a single gel was sliced, eluted, 
and assayed for bradykinin-generating activity, the single  activity previously 
observed at  15-16 mm (Table I)  was no longer apparent,  and two peaks  of 
activity at 19-21 mrn and 24-25 mm were observed. The activity at 19-21 mm 
was intermediate in position relative to the original activity of peaks 4 and 5, 
while the activity at 24-25 mm corresponded to the position of peak 5. Analysis 
of peak 5 by disc gel electrophoresis after filtration on Sephadex G-100 did not 
reveal  a  shift in  elution position; bradykinin-generating activity was found 
between 23 and 26 ram. 
Formation  of the  Prealbumin-Prekallikrein  Activator  by  the  Interaction  of 
Aclive ttageman Factor and Streptokinase-Activated  Plasminogen.-- 
Enhancement  of bradykinin-generating  activity  by the interaction  of activated 
ttageman factor with streptokinase-activated plasminogen:  The observation that 
a plasma fraction could be separated, activated, and then fractionated to yield 
materials  of progressively greater  negative charge and  smaller size,  each  of 
which possessed  the ability to correct Hageman factor deficiency and to con- 
vert prekallikrein to kallikrein, suggested that progressive digestion of active 
Hageman factor had occurred. Any enzyme responsible for this digestion must 
have been present in the effluent of the initial batch eluate  of  plasma  from 
DEAE-cellulose in which the column and plasma were equilibrated with 0.05 
PO4 buffer, pH 7.5; further, the enzyme must also elute from DEAE-cellulose 
close to Hageman factor since prekallikrein-activating activity has been shown 
to be generated from partially purified preparations  of Hageman factor (5). 
Plasmin has been implicated in the activation of prekallikrein (7);  therefore, 
plasminogen and plasmin were sought in  the fractions obtained by I)EAE- 
cellulose chromatography of whole serum. Fractions were pooled, concentrated 
10-fold,  and  assessed  for plasminogen  and  plasmin  content by  cleavage  of 
azocasein with and without the prior addition of streptokinase. Plasminogen ALLEN  P.  KAPLAN AND  K.  FRANK  AUSTEN  703 
and plasmin were found between 0.06 and 0.12  M NaC1 overlapping peak 3 and 
the  descending  half  of peak  2.  The peak  of  plaslnin  activity just  preceded 
plasminogen. 
An  experiment was  designed  in  which  partially  purified  active  Hageman 
factor was  incubated with  streptokinase-activated plasminogen  to determine 
FIG. 3. A chymograph recording of contractions of the guinea pig ileum obtained when 
active Hageman factor (A), streptokinase-activated  plasminogen (B), and a mixture of active 
Hageman factor preincubated with streptokinase-acfivated plasminogen (A +  B) are incu- 
bated with fresh plasma and assayed for bradykinin. The first determination contains 10/~l 
of active Hageman factor  (A) and 25 /~1 of streptokinase-acfivated plasminogen (B); the 
second and third  determinations contain double and triple the quantity  of the reactants, 
respectively. 
whether prekallikrein-activating activity was generated. Unactivated Hageman 
factor  obtained  from  I)EAE-cellulose  chromatography  of  plasma  (5)  was 
pooled, concentrated, dialyzed, and chromatographed on CM-cellulose. Active 
Hageman factor was eluted at 0.6 ~t NaC1,  concentrated, and further purified 
by elution from disc gels  after electrophoresis at  pH 9.3.  The peak activity 
at 5-6 ram,  free of plasminogen  and plasmin,  was  pooled from six disc gels 
and concentrated to 1 ml. 50/zl of this preparation shortened the partial throm- 
boplastin  time  of  Hageman  factor-deficient plasma  from 40  to  6  rain  and 704  A  PREALBUMIN  ACTIVATOR  OF  PREKALLIKREIN.  II. 
generated  10  ng  of bradykinin  when  incubated  with fresh  plasma;  the  only 
identifiable  contaminant  of  active Hageman factor was  IgG. A  preparation 
of purified plasminogen which gave a  single band after either disc gel electro- 
phoresis  at  pH 4.3  or  isoelectric focusing  in  gels  (isoelectric  point  5.9)  was 
activated with streptokinase and generated 20 azocaseinolytic units of plasmin 
per  milliliter.  The  streptokinase  preparation  used  gave  four  bands  located 
between  transferrin  and  albumin  after  disc  gel  electrophoresis  at  pH  9.3, 
each  band  disappearing  after  interaction with plasminogen. 
Three  mixtures  of  streptokinase-activated  plasminogen  and  active  Hage- 
man factor at a volume ratio of 2.5:1  were assessed for total bradykinin-gen- 
TABLE II 
Activation of Prekallikrein by a Mixture of Hageman  Factor and Streptokinase-Activated 
Plasminogen  (  Plasmin  ) * 
Brady- 
A  +  B  +  C  +  D  klnin 
generated 
(0.03 ml)  (0.075 ~nl)  (0.01 ml)  (0.2 ml)  (rig) 
Buffer  Plasmin  Buffer  Heat-inactivated plasma  10 
Hageman factor  Plasmin  Buffer  Heat-inactivated plasma  10 
Buffer  Plasmin  Prekallikrein  Heat-inactivated plasma  15 
Hageman factor  Plasmin  Prekallikrein  Heat-inactivated plasma  50 
Hageman factor  Buffer  Prekallikrein  Heat-inactivated plasma  0 
Hageman factor  Buffer  Buffer  Heat-inactivated plasma  0 
Buffer  Buffer  Prekallikrein  Heat-inactivated plasma  0 
* Column A was incubated with column B for 5 min at 37°C; C was then added and the 
mixture again incubated for 5 min at 37°C, and then D was added. After incubation for 2 
rain at 37°C, the bradykinin generated was measured. 
crating activity. The response when 10, 20, and 30 #1 of active Hageman factor 
was  reacted  with  25,  50,  and  75  #1  of  streptokinase-activated  plasminogen, 
respectively,  is shown  in  Fig.  3.  Neither  the  active Hageman factor nor  the 
streptokinase-activated plasminogen alone generated a  significant quantity  of 
bradykinin when incubated with fresh plasma. The mixtures of active Hageman 
factor  and  streptokinase-activated  plasminogen  generated  bradykinin  in 
proportion  to  the quantities  of the reactants present.  The same results were 
obtained when an active Hageman factor and streptokinase-activated plasmino- 
gen  mixture  was  incubated  with  prekallikrein  and  then  assayed with  heat- 
inactivated plasma (Table II). The plasmin preparation under these conditions 
was  capable  of  generating  10  ng  of  bradykinin  when  incubated  with  heat- 
inactivated  plasma,  indicating  some  kininogenase  activity.  Incubation  of 
plasmin  with  Hageman  factor  did  not  increase  the  bradykinin-generating 
activity of the mixture relative to that of plasmin alone. Incubation of plasmin ALLEN  P.  KAPLAN  AND  K.  FRANK AUSTEN  705 
with  prekallikrein  increased  the  bradykinin  generated  by 5  ng  above  that 
accounted for by plasmin alone. Incubation  of plasmin with Hageman factor 
and  then  prekallikrein  produced three times more bradykinin  than  could be 
accounted for by the ability of plasmin to directly activate prekallikrein or to 
act as a kininogenase.  A prekallikrein  activator must therefore have resulted 
from the interaction  of plasmin with Hageman factor. 
FIG. 4,  Disc gel electrophoresis  of  mixtures  of active Hageman  factor with  buffer  (1), 
plasminogen  (2),  streptokinase  (3),  and streptokinase-activated plasminogen (4) 
Characterization of the prekallikrein activator  formed  by the interaction of active 
ttageman  factor  and  streptokinase-activated  plasminogen:  The  prekallikrein 
activator generated by the interaction of streptokinase-activated plasminogen 
and active Hageman factor was sought by examination  of the incubation mix- 
ture by disc gel electrophoresis.  The experiment was initially  carried out with 
highly purified Hageman factor obtained by DEAE-celtulose chromatography, 
C1VLcellulose chromatography, and elution from disc gels after electrophoresis 
at  pH  9.3. This  experiment  demonstrated  that  the  prekallikrein-activating 706  A  PREALBUMIN  ACTIVATOR OF  PREKALLIKREIN. II. 
activity appeared in the prealbumin region but the protein concentration was 
not  sufficient  to  reveal  visible  protein  bands.  Accordingly,  the  study  was 
repeated  with  Hageman  factor  eluted  from  DEAE-cellulose  employing  the 
ascending portion of peak 2 which was free of plasminogen and plasnfin. 200 
#1 of active Hageman factor was allowed to react with 300 #1 of either buffer, 
plasminogen,  streptokinase,  or  streptokinase-activated  plasminogen  for  5 
rain  at 37°C.  150/4  of each mixture was  then  applied  to  two disc gels and 
electrophoresed at pH 9.3. One gel of each mixture was stained and the other 
sliced,  eluted,  and  assayed for bradykinin-generating activity and  Hageman 
factor activity. As  shown  in  Fig.  4,  the  disc  gel  containing  the mixture  of 
FIO. 5. A chymograph recording  of the bradykinin generated when the eluates of the bot- 
tom 12 mm of the disc gels shown in Fig. 4 (30 mm-18 mm) are incubated with fresh plasma. 
Preceding the eluates of each disc gel is a 10 ng bradykinin standard contraction. 
active  Hagemen  factor  and  streptokinase-activated  plasminogen  had  four 
bands visible in the prealbumin region from 20 to 25 ram, whereas, prealbumin 
bands were not seen when active Hageman factor was interacted with either 
buffer, plasminogen, or streptokinase. The disc gel eluate of the active Hageman 
factor--streptokinase-activated  plasminogen  mixture  contained  bradykinin- 
generating activity in the prealbumin region from 21  to 25 mm (Fig. 5). The 
disc gel eluates of the mixtures of Hageman factor with buffer, plasminogen, 
and streptokinase did not contain bradykinin-generating activity. Incubation 
of  active  Hageman  factor with  either  buffer,  plasminogen,  or  streptokinase 
failed to generate  clot-promoting activity in  the prealbumin  region;  in  each 
case active Hageman factor could be located between 1 and 9 ram. On the other 
hand, depletion of Hageman factor activity between 1 and 9 mm was found in 
the mixture of active Hageman factor and streptokinase-activated plasmino- 
gen accompanied by the appearance of such activity at  10 mm and again at 
21-25 mm in the prealbumin region (Table II1) corresponding to the location 
of  the  bradykinin-generating  activity  (Fig.  5)  and  the  prealbumin  bands ALLEN P.  KAPLAN AND  K.  FRANK AUSTEN  707 
(Fig. 4).  The  presence  of  plasmin  in  the  mixture  did not  interfere with  the 
clotting test;  the plasrnin preparation spread between  7  and  10  mm  in  disc 
gels at pH 9.3,  precipitated in the gel, and was inactivated by the procedure. 
DISCUSSION 
It was previously shown  that when human  serum was chromatographed on 
DEAE-cellulose,  four  peaks  of  bradykinin-generating  activity  were  found 
TABLE III 
ttageman Factor Activity in Disc Gel Eluates* 
Slices  Disc 1  Disc 2  Disc 3  Disc 4 
(mm) 
1  14  12  43  52 
2  11  12  12  52 
3  8  17  17  52 
4  8  15  8  33 
5  10  11  8  42 
6  16  15  17  48 
7  34  12  14  41 
8  41  20  19  41 
9  36  30  28  41 
10  57  43  46  33 
11-20  45-60  45--60  45-60  45-60 
21  52  60  55  37 
22  53  54  56  33 
23  53  53  58  32 
24  50  55  57  36 
25  57  57  44  44 
26  51  54  57  57 
27  60  54  57  60 
28  57  58  51  58 
29  55  53  51  55 
30  45  57  45  60 
* Disc gels of mixtures described in the legend to Fig. 4. The partial thromboplastin time 
in minutes is shown for the eluate of each slice of each gel. 
(peaks 2-5), each of which was capable of converting prekallikrein to kallikrein 
(5). Hageman factor overlapped peaks 2 and 3,  and this region was capable of 
generating  a  prekallikrein  activator  with  the  same  characteristics  as  that 
present in peak 5.  Further,  the  capacity of  the prealbumin prekallikrein ac- 
tivator  to  shorten  specifically the  partial  thromboplastin  time  of  Hageman 
factor-deficient  plasma  suggested  that  it  represented  a  fragment  of  active 
Hageman factor. Additional characterization of the four prekallikrein-activat- 
ing peaks obtained from DEAE-cellulose was pursued by isolating a  mixture 708  A  PREALBUMIN ACTIVATOR  O~F  PREKALLIKREIN. II. 
of unactivated Hageman factor and prekallikrein by batch elution from DEAE- 
cellulose.  When  this  effluent  was  activated  and  then  chromatographed  on 
DEAE-cellulose, active kallikrein  and  three  prekallikrein-activating  fractions 
(peaks 2-3, 4,  and 5) were obtained  (Fig.  1)  in positions similar  to those ob- 
served when  the kinin-forming  system was fractionated from serum  after its 
activation by clotting. After disc gel electrophoresis at  pH  9.3,  peak  2-3 was 
resolved  into  two  peaks  of  bradykinin-generating  activity  (Table  I).  The 
first peak  at 5-8  mm was associated with  a  major peak  of Hageman factor 
activity and the second peak at 11-12 mm was accompanied by a  small  peak 
of Hageman factor activity. The activities observed at 5-8 mm and 11-12 mm 
correspond to peaks 2 and 3  eluted after DEAE-cellulose chromatography  of 
serum,  and  it seems likely that peak 3 represents an early alteration of active 
Hageman  factor resulting  in a  slight  increase in negative charge  and  greater 
bradykinin-generating  activity relative to clot-promoting activity. The demon- 
stration  that peak 4 is intermediate  in size relative to peaks 2-3 and 5,  has a 
negative charge greater than peak 3 but less than  peak 5,  and manifests pre- 
kallikrein-activating  activity  with  associated  Hageman  factor  activity  sug- 
gests that  peak 4  is a  further  breakdown product of active Hageman  factor. 
The  subsequent  conversion  upon  disc  gel  electrophoresis  of  peak  4  to  two 
peaks located closer to the anode than peak 4 indicates the existence of inter- 
mediate  fragments  as peak 4  converts  to peak  5.  Peak  5,  as  described pre- 
viously  (5),  contained  multiple  prealbumin  bands  (Fig.  2)  which  possessed 
relatively greater prekallikrein-activating  activity than clot-promoting activity 
when compared with peak 2 material. 
Progressive  fragmentation  of  active  Hageman  factor  appears  to  result  in 
the formation of at least three types of fragments capable of correcting Hage- 
man factor deficiency. Fragments  in the prealbumin region  (Table I,  peak 5: 
20-26 ram)  possessed strikingly greater  prekallikrein-activating  activity rela- 
to  clot-promoting  activity  when  compared  with  the  parent  Hageman  factor 
molecule (Table I, peak 2-3:5-8 mm). Fragments whose ratio of prekallikrein- 
activating  activity  to  clot-promoting  activity  was  intermediate  when  com- 
pared with Hageman factor and  the prealbumin-prekallikrein  activator were 
generally  located  between  11  and  20 ram.  However,  within  this  region  are 
fragments  having  comparable  clot-promoting  activity  but  no  detectable 
bradykinin-generating  activity. It  therefore appears likely that  a  specific site 
required  for  the  conversion  of prekallikrein  to kallikrein  is present  in  active 
Hageman  factor.  The  formation  of  progressively  smaller  fragments  which 
retain  this  site  increases  their  efficiency in  converting  prekallikrein  to kalli- 
krein  and  decreases  their  ability  to  accelerate  coagulation.  Other  fragments 
lacking this prekallikrein-activating  site are apparently formed as detected by 
their clot-promoting activity, although one cannot rule out the possibility that 
these  represent  nonspecific  aggregation  of  smaller  fragments  analogous  to ALLEN  P.  KAPLAN  AND  K.  FRANK  AUSTEN  709 
the aggregation  observed for the parent Hageman factor molecule  (Table I, 
peak 2-3:1-4 ram)  (14),  resulting in masking of the prekallikrein-activating 
site. 
The possibility that plasmin might be the enzyme which cleaves Hageman 
factor was considered  because it has been implicated in the activation of pre- 
kallikrein  (7) and was detectable in preparations  of highly purified  Hageman 
factor (6). When plasmin was sought on the DEAE-cellulose chromatogram, 
it eluted overlapping peaks 2 and 3. Incubation of partially purified Hageman 
factor (peak 2) with streptokinase-activated plasminogen  resulted in a striking 
increase  in  bradykinin-generating  activity  employing  fresh  plasma  as  sub- 
strate  (Fig.  3).  The  mixture  of  active  Hageman  factor  and  streptokinase- 
activated  plasminogen  was  also  active  in  generating  bradykinin  upon  se- 
quential  interaction  with  prekallikrein  and  heat-inactivated  plasma  (Table 
II). The latter effect is attributed  to the formation of the prekallikrein  acti- 
vator  and  was not  explicable  by the kininogenase  activity of plasmin  or  a 
direct activation of prekallikrein  by plasmin. 
The products of the interaction of active Itageman factor and streptokinase- 
activated  plasminogen  were  therefore  evaluated  by  elution  from  disc  gels 
after electrophoresis  at pH 9.3 and assayed for bradykinin-generating activity 
and  Hageman factor  activity.  As  shown  in  Fig.  4,  prealbumin  bands  were 
present in a location similar  to that observed upon disc gel electrophoresis  of 
peak 5 obtained upon DEAE-cellulose chromatography of serum (5)  or con- 
tact activation of a plasma fraction containing  unactivated Hageman factor, 
plasminogen,  and  prekallikrein  (Fig.  2).  Elution  of  the  prealbumin  region 
(Fig.  5)  confirmed  the  association  of  prekallikrein-activating  activity  with 
these bands  and  accounted for the enhanced  bradykinin-generating  activity 
of the starting mixture. A small peak of Hageman factor activity located be- 
tween 21 and 25 mm (Table III) was associated with those slices having pre- 
kallikrein-activating  activity,  and  a  significant  depletion of Hageman factor 
actvity was observed between 1 and 9 mm. This interaction  of plasmin  and 
active Hageman factor under the conditions  described resulted in the forma- 
tion  of  prealbumln-prekallikrein-activating  activity  indistinguishable  from 
that appearing upon the contact activation of Hageman factor in the presence 
of other serum proteins including  plasminogen. 
Nagasawa et al. (15) have reported that purified activated bovine Hageman 
factor was capable of converting bovine prekaUikrein  to kallikrein;  and Davies, 
Holman,  and Lowe (16) have reported similar  results in the guinea pig.  Al- 
though human Hageman factor (peak 2) appears to be capable of converting 
human  prekallikrein  to  kallikrein,  the  digestion  of  active human  Hageman 
factor by plasmin  appears to generate fragments having enhanced ability to 
activate  prekallikrein.  The  conversion  of plasminogen  to  plasmin  therefore 
appears necessary for maximal generation of bradykinin when human plasma 710  A  PREALBUMIN  ACTIVATOR  OR  PREKALLIKREIN.  II. 
is  activated.  It  should be  noted  that  the  generation  of plasmin  activity is 
believed to be  dependent upon the prior  activation of Hageman factor (17) 
and the participation of a  cofactor termed "Hageman factor cofactor" (18). 
Hageman  factor  cofactor  elutes  from  DEAE-cellulose  with  kallikrein  and 
PTA and after further purification could be distinguished from plasma kalli- 
krein but not from PTA,  although the activity could be  detected in PTA- 
deficient plasma. These studies suggest a scheme by which bradykinin may be 
generated in human plasma (Fig. 6). It is dependent upon the initial activation 
of Hageman factor resulting in conversion of plasminogen to plasmin. Digestion 
of  active Hageman  factor  by  plasmin then liberates  fragments having en- 
ACTIVATED  HAGEMAN FACTOR 
H#geman Fee/or 
Cofac/or 
%%. 
-=  HAGEMAN FACTOR FRAGMENTS 
PLASMINOGEN  p  PLASMIN  PRE KALLIKREIN  "~  ~ KALLIKREIN 
KININOGEN  ~  BRADYKININ 
Fro. 6. Schematic  diagram of the pathway by which bradykinin is generated when Hage- 
man factor is activated in human plasma. Although  activated Hageman  factor may be capable 
of converting  prekaUikrein to kallikrein, shown  by the dotted line, activation of plasmin and 
cleavage of active Hageman  factor by plasmin,  forming  fragments of active Hageman factor 
which activate prekallikrein,  appears to be the major pathway. 
hanced ability to convert prekallikrein to kallikrein. This scheme represents one 
pathway in which coagulation, fibrinolysis, and inflammation are linked. 
SUMMARY 
Activation of a plasma fraction  containing  unactivated Hageman factor  and 
prekallikrein  followed by chromatography of this  fraction  on DEAE-cellulose 
revealed four peaks having bradykinin-generating activity.  Peak 1 contained 
kallikrein; peaks 2-3, 4, and 5 each contained prekallikrein-activating activity. 
Elution of peaks 2-3,  4,  and 5 from disc gels  after electrophoresis at pH 9.3 
revealed  peaks  of  prekallikrein-activating  activity  located  at  5-8,  11-12, 
15-16,  and 20-26 ram, each of which was associated with a  peak of clot-pro- 
moting activity which specifically corrected Hagelnan factor deficiency. Con- 
version of peak 2 to peaks 3, 4,  and 5 was associated with a  progressive de- 
crease in size, increase in net negative charge, increased prekallikrein-activating ALLEN P.  KAPLAN AND  K.  FRANK AUSTEN  711 
activity,  and  decreased  ability  to  correct  Hageman  factor  deficiency.  Plas- 
minogen and plasmin were found on a DEAE-cellulose chromatogram of serum 
overlapping peaks 2 and 3. Incubation of active Hageman factor with strepto- 
kinase-activated  plasminogen  resulted  in  enhanced  ability  of  the  mixture 
to activate prekallikrein. Assessment of the products  of this reaction by disc 
gel electrophoresis demonstrated the formation of the prealbumin prekallikrein 
activator corresponding to the major prekallikrein activator generated by con- 
tact activation of human plasma. The conversion of plasminogen to plasmin 
and the subsequent cleavage of Hageman factor by plasmin to form activators 
of prekallikrein represents one pathway in which coagulation, fibrinolysis, and 
inflammation are linked. 
We are grateful for the excellent technical assistance provided by Miss Pamela Reducha. 
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